[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017 Japan Automated Microbiology Market: New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

March 2017 | 421 pages | ID: J97B6A26AA6EN
Venture Planning Group

US$ 7,965.00 US$ 8,850.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $8,850. DataPack (test volumes, sales forecasts, supplier shares) $5,700.

VPGMarketResearchs new report is an analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the Japanese automated microbiology market; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Supplier Shares, Sales and Volume Forecasts
  • Sales and market shares of major suppliers of microbiology products, by individual test.
  • Five-year test volume and sales forecasts for over 100 microbiology assays.
  • Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
Japan Market Overview
  • Review of the market dynamics, trends, structure, size, growth and major suppliers.
  • Estimated universe of laboratories performing microbiology testing.
  • Specimen, test volume and sales forecasts.
Business Opportunities and Strategic Recommendations
  • Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
  • Design criteria for decentralized testing products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
Specimen Types
  • Urine
  • Sterile Fluids: Blood, Serum, CSF
  • Throat Swabs, Respiratory Secretions
  • Genital Secretions
  • Stool
  • Abscess/Wound
  • Sputum
  • Saliva
Applications
  • Microbial Identification
  • Antibiotic Susceptibility
  • Urine Screening
  • Blood Cultures
Review of Major Automated Systems
  • Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.
  • The report features analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.
Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia and others.

Technology Assessment
  • Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
  • Global listings of companies developing or marketing microbiology products by individual test.
Competitive Strategies

Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D. The companies analyzed in the report include:
  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper Life Sciences
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan
  • Thermo Fisher
  • Wallac/PE
  • Wako

    Contains 421 pages and 79 tables
1. INTRODUCTION

2. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

    a. INTRODUCTION

  1. MAJOR FACTORS AFFECTING MARKET PENETRATION
of Microbiology INSTRUMENTATION
  2. TRADITIONAL PRACTICES
  3. TECHNOLOGICAL CHALLENGES
  4. AUTOMATION: IMPACT ON THE MICROBIOLOGY
Laboratory and the Patient
    b. Major Specimen Types
  1. URINE
  2. STERILE FLUIDS: BLOOD, SERUM, AND CSF
  3. THROAT SWABS AND RESPIRATORY SECRETIONS
  4. GENITAL SECRETIONS
  5. STOOL
  6. ABSCESS/WOUND
  7. SPUTUM
  8. SALIVA
    c. Test Applications
  1. MICROBIAL IDENTIFICATION
  2. ANTIBIOTIC SUSCEPTIBILITY
  3. URINE SCREENING
    a. Photometry
    b. Bioluminescence
    c. Colorimetric Filtration
    d. Enzymatic Detection
    e. Optical Detection
  4. BLOOD CULTURES
    d. Major Microbiology Automated and Semiautomated Systems
  1. MULTIPLE PURPOSE MICROBIOLOGY SYSTEMS
  2. SPECIALIZED MICROBIOLOGY SYSTEMS
  3. MOLECULAR DIAGNOSTIC SYSTEMS
  4. IMMUNODIAGNOSTIC SYSTEMS
    e. Emerging Diagnostic Technologies
  1. MOLECULAR DIAGNOSTICS (AMPLIFICATION METHODS, SEQUENCING, MICROARRAYS/BIOCHIPS)
    a. DNA Sequencing

INTRODUCTION

Sequencing Methods
Autoradiography
The Human Genome Project
Sequencing Automation
Image Scanners
Fluorescent Detection
Gene Profiling
Gene Expression
Polymorphism Screening
Protein Interaction Networks
    b. DNA And RNA Probe Technology
Basic Principles
Probe Preparation
The DNA Probe Test
  Sample Preparation
  Hybridization
  Separation
  Detection/Measurement
Test Formats
  Filter Hybridization
  Southern Blot
  Northern Blot
  In Situ Hybridization
  Others
Labeling Techniques
Amplification Methods
      Polymerase Chain Reaction
  Temperature Cyclers
  PCR Variations
    Immuno PCR
    QC PCR
    DAP PCR
      Strand Displacement Activation
      TMA
      Ligase Chain Reaction
      Branched DNA
  Hybridization Protection Assay
      NucleiC Acid Sequence Based Amplification
      Self Sustained Sequence Replicase
      Others
  Ampliprobe
  CAR
  CAS
  CPT
  Dendritic Polymer Technology
  ISo CR
  LAT
  Probe
  RAMP
  Repair Chain Reaction
  Rolling Circles
  Sequence Independent Gene Amplification
  Sequence Initiation Reaction
  SISPA
  Solid Phase Amplification
    c. Detection Technologies
Radioactive Methods
  Overview
  Major Isotopes
      P
      S
      H
      I
NonIsotopic Methods
  Enzymatic Labels
  Chemical Labeling
      Indirect Chemical Labeling
      Direct Chemical Labeling
  Fluorescence
  Chemiluminescence
  Electrical Conductivity
    d. Biochips: Genosensors, Microarrays, and Labs  onthe Chip
  Liquid Transportation and Mixing
  Separation
  Reaction
  Detection
  2. MONOCLONAL ANTIBODIES
  3. IMMUNOASSAYS
  4. DIFFERENTIAL LIGHT SCATTERING
  5. INFORMATION TECHNOLOGY
  6. ARTIFICIAL INTELLIGENCE
  7. LIPOSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. DIAGNOSTIC IMAGING
  11. GEL MICRODROPLETS
  12. OTHER

3. JAPAN

    a. Business Environment
    b. Market Structure
    c. Market Size, Growth and Major Supplier Sales and Market Shares

4. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

5. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

6. ALTERNATIVE MARKET PENETRATION STRATEGIES

    a. Internal Development
    b. Collaborative Arrangements
    c. University Contracts
    d. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

7. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    a. Market Maturity
    b. Cost Containment
    c. Competition
    d. Technological Edge and Limitations
    e. Patent Protection
    f. Regulatory Constraints
    g. Decentralized Testing Market Challenges

8. COMPETITIVE ASSESSMENTS

  Abbott
  Affymetrix
  Agilent Technologies
  Applied Gene Technologies
  Arca Pharma
  Beckman Coulter/Danaher
  Becton Dickinson
  Biokit
  bioMerieux
  Bio Rad
  Biotest
  Cepheid
  CellMark Forenciscs/Lab Corp
  Decode Genetics
  Diadexus
  Diamedix
  DiaSorin
  Eiken Chemical
  Elitech Group
  EnzBiochem
  Exact Sciences
  Fujirebio
  Grifols
  Hologic/GenProbe
  Illumina
  ID Biomedical/GSK
  Kreatech/Leica
  LiCor Biosciences
  Lonza
  Monogram Biosciences
  Myriad Genetics
  Ortho Clinical Diagnostics
  Perkin Elmer/Caliper
  Proteome Sciences
  Qiagen
  Roche
  Scienion
  Sequenom
  SeraCare
  Siemens
  Sierra Molecular
  Shimadzu
  Takara Bio
  Tecan
  ThermFisher
  Wallac/PE
  Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Japan Laboratories Performing Microbiology Tests by Market Segment
Japan Hospital Laboratories Performing Microbiology Tests by Bed Size
Japan Commercial/Private Laboratories Performing Microbiology Tests by Annual Test Volume
Japan All Market Segments Microbiology Specimen Volume
Japan Hospital Laboratories Microbiology Specimen Volume
Japan Commercial/Private Laboratories Microbiology Specimen Volume
Japan Microbiology Test Volume by Market Segment
Japan Microbiology Test Volume by Application
Japan Urine Screening Test Volume by Market Segment
Japan Microbial Identification Test Volume by Market Segment
Japan Blood Culture Test Volume by Market Segment
Japan Antibiotic Susceptibility Test Volume by Market Segment
Japan Microbiology Consumables Market by Application
Japan Microbiology Consumables Market by Market Segment
Japan Microbial Identification Consumables Sales by Market Segment
Japan Blood Culture Consumables Sales by Market Segment
Japan Antibiotic Susceptibility Consumables Sales by Market Segment
Japan Urine Screening Consumables Sales by Market Segment
Japan All Market Segments Infectious Disease Test Volume Forecast by Assay
Japan All Market Segments Infectious Disease Diagnostics Market Forecast by Test
Japan Infectious Disease Blood Screening NAT Volume Forecast by Assay
Japan Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Japan HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
Japan HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales by Major Supplier
Japan Campylobacter Testing Market Diagnostics Sales by Major Supplier
Japan Candida Testing Market Diagnostics Sales by Major Supplier
Japan Chlamydia Testing Market Diagnostics Sales by Major Supplier
Japan CMV Testing Market Diagnostics Sales by Major Supplier
Japan Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Japan Hepatitis Testing Market Diagnostics Sales by Major Supplier
Japan Hepatitis C Testing Market Diagnostics Sales by Major Supplier
Japan Herpes Testing Market Diagnostics Sales by Major Supplier
Japan Legionella Testing Market Diagnostics Sales Forecast by Major Supplier
Japan Meningitis Testing Market Diagnostics Sales by Major Supplier
Japan Mononucleosis Testing Market Diagnostics Sales by Major Supplier
Japan Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Japan Pneumonia Testing Market Diagnostics Sales by Major Supplier
Japan RSV Testing Market Diagnostics Sales by Major Supplier
Japan Rotavirus Testing Market Diagnostics Sales by Major Supplier
Japan Rubella Testing Market Diagnostics Sales by Major Supplier
Japan Septicemia Testing Market Diagnostics Sales by Major Supplier
Japan Shigella Testing Market Diagnostics Sales by Major Supplier
Japan Streptococci Testing Market Diagnostics Sales by Major Supplier
Japan Syphilis Testing Market Diagnostics Sales by Major Supplier
Japan Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Japan Trichomonas Testing Market Diagnostics Sales by Major Supplier
Japan Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Japan Molecular Diagnostics Market Sales and Shares of Major Suppliers


More Publications